Drugs Archives - Express Pharma

Scientists find potential new drug target to prevent Ebola

AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

Sanofi to focus on 12 blockbuster drug candidates, immunology pipeline

IPC issues alert against adverse reactions of painkiller Meftal

Pfizer to price COVID treatment Paxlovid at $1,390 per course

Lupin receives USFDA approval for Chlorpromazine Hydrochloride tablets

Enzene Biosciences launches Bevacizumab

Prices of 103 formulation packs to come down after NPPA cap

DCG(I) bans 344 drugs constituting fixed dose combinations, but will it hold?

NPPA seeks to recover Rs 4,551 crore for overcharging